Developed a sensitive spectrophotometric method detecting hesperidin in pharmaceutical forms, highlighting eco-friendly cloud point extraction.
A spectrophotometric method was developed for the determination of hesperidin (HSP) in pharmaceutical preparations and bulk powder, characterized by sensitivity, simplicity, and ecofriendliness. The method involves diazotization of p-chloroaniline (PCA), followed by coupling with HSP in an alkaline medium. The resulting azo product is extracted using the cloud point extraction (CPE) with Triton X-114, and the absorbance was measured at 437 nm. Two approaches were used, i.e., the batch spectrophotometric method and the CPE technique. The batch method showed a detection limit of 0.409 μg/mL, while the CPE method achieved a significantly lower detection limit of 0.023 µg/mL. The linearity ranges were 3–40 and 1–8.5 μg/mL of HSP for the batch and CPE methods. Both methods demonstrated high precision (RSD < 1.17%) and excellent recovery rates, 99.18 to 102.27% for the batch method and 97.32 to 104.28% for CPE, with an enrichment factor of 4.7 using CPE. The methods were successfully applied to the analysis of HSP in supplement formulations and spiked urine samples without significant interference. A greenness evaluation using AGREE software confirmed its environmentally friendly nature. The proposed method offers a reliable, green, low-cost analytical approach suitable for routine pharmaceutical quality control in laboratories to analyze HSP in dosage forms.
No takes yet. Share an insight, caveat, or question.
Salman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: